日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris

氧吲哚外排抑制剂可增强唑类药物的作用并削弱真菌病原体耳念珠菌的毒力

Kali R Iyer, Kaddy Camara, Martin Daniel-Ivad, Richard Trilles, Sheila M Pimentel-Elardo, Jen L Fossen, Karen Marchillo, Zhongle Liu, Shakti Singh, José F Muñoz, Sang Hu Kim, John A Porco Jr, Christina A Cuomo, Noelle S Williams, Ashraf S Ibrahim, John E Edwards Jr, David R Andes, Justin R Nodwell, 

In Vivo Pharmacodynamic Evaluation of Omadacycline against Staphylococcus aureus in the Neutropenic Mouse Pneumonia Model

在嗜中性粒细胞减少小鼠肺炎模型中,对奥马环素抗金黄色葡萄球菌的体内药效学评价

Lepak, Alexander J; Zhao, Miao; Marchillo, Karen; VanHecker, Jamie; Andes, David R

APX001 Pharmacokinetic/Pharmacodynamic Target Determination against Aspergillus fumigatus in an In Vivo Model of Invasive Pulmonary Aspergillosis

在侵袭性肺曲霉病体内模型中,确定 APX001 抗烟曲霉的药代动力学/药效学靶点

Zhao, Miao; Lepak, Alexander J; Marchillo, Karen; Vanhecker, Jamie; Sanchez, Hiram; Ambrose, Paul G; Andes, David R

In Vivo Pharmacodynamics of Omadacycline against Staphylococcus aureus in the Neutropenic Murine Thigh Infection Model

奥马环素在嗜中性粒细胞减少小鼠大腿感染模型中抗金黄色葡萄球菌的体内药效学研究

Lepak, Alexander J; Zhao, Miao; Marchillo, Karen; VanHecker, Jamie; Andes, David R

In Vivo Pharmacodynamic Target Determination for Delafloxacin against Klebsiella pneumoniae and Pseudomonas aeruginosa in the Neutropenic Murine Pneumonia Model

在嗜中性粒细胞减少的小鼠肺炎模型中,对德拉沙星抗肺炎克雷伯菌和铜绿假单胞菌的体内药效学靶点进行测定

Zhao, Miao; Lepak, Alexander J; Marchillo, Karen; Andes, David R

In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model

在嗜中性粒细胞减少性播散性念珠菌病小鼠模型中,APX001 抗念珠菌属的体内药代动力学和药效学研究

Zhao, Miao; Lepak, Alexander J; VanScoy, Brian; Bader, Justin C; Marchillo, Karen; Vanhecker, Jamie; Ambrose, Paul G; Andes, David R

Identification of the In Vivo Pharmacokinetics and Pharmacodynamic Driver of Iclaprim

伊克拉普林体内药代动力学和药效学驱动因素的鉴定

Park, Jee Hyun; Craig, William; Marchillo, Karen; Huang, David B; Andes, David R

In Vivo Pharmacodynamic Characterization of a Novel Odilorhabdin Antibiotic, NOSO-502, against Escherichia coli and Klebsiella pneumoniae in a Murine Thigh Infection Model

在小鼠大腿感染模型中,对新型奥迪洛拉布丁类抗生素NOSO-502进行体内药效学表征,以评估其对大肠杆菌和肺炎克雷伯菌的疗效。

Zhao, Miao; Lepak, Alexander J; Marchillo, Karen; VanHecker, Jamie; Andes, David R

In Vivo Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia Model

在小鼠肺炎模型中对奥马环素(PTK 0796)抗肺炎链球菌的体内药效学评价

Lepak, Alexander J; Zhao, Miao; Marchillo, Karen; VanHecker, Jamie; Andes, David R

In Vivo Pharmacodynamic Target Assessment of Eravacycline against Escherichia coli in a Murine Thigh Infection Model

在小鼠大腿感染模型中对依拉环素抗大肠杆菌的体内药效学靶点进行评估

Zhao, Miao; Lepak, Alexander J; Marchillo, Karen; VanHecker, Jamie; Andes, David R